160 related articles for article (PubMed ID: 37324936)
1. TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation.
Sun Y; Lin P; Zhou X; Ren Y; He Y; Liang J; Zhu Z; Xu X; Mao X
Int J Biol Sci; 2023; 19(9):2803-2816. PubMed ID: 37324936
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
4. The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma.
Wang Z; Xia Y; Wang Y; Zhu R; Li H; Liu Y; Shen N
Cell Death Dis; 2023 Oct; 14(10):695. PubMed ID: 37872147
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.
Wang K; Chai L; Qiu Z; Zhang Y; Gao H; Zhang X
J Cell Physiol; 2019 Aug; 234(10):19019-19027. PubMed ID: 30927273
[TBL] [Abstract][Full Text] [Related]
8. Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma.
Lu T; Wu Y
Horm Metab Res; 2022 Dec; 54(12):859-865. PubMed ID: 36108622
[TBL] [Abstract][Full Text] [Related]
9. TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.
Zhong T; Zhang J; Liu X; Li H
Cell Oncol (Dordr); 2023 Oct; 46(5):1493-1507. PubMed ID: 37219768
[TBL] [Abstract][Full Text] [Related]
10. TRIM11 promotes cell proliferation of non-small cell lung cancer through the inhibition of ferroptosis by AMPK.
Liang Z; Li J; Zhang G; Chen M
Clin Respir J; 2023 Oct; 17(10):1006-1016. PubMed ID: 37604203
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.
Mahlokozera T; Patel B; Chen H; Desouza P; Qu X; Mao DD; Hafez D; Yang W; Taiwo R; Paturu M; Salehi A; Gujar AD; Dunn GP; Mosammaparast N; Petti AA; Yano H; Kim AH
Nat Commun; 2021 Nov; 12(1):6321. PubMed ID: 34732716
[TBL] [Abstract][Full Text] [Related]
12. TRIM26 restricts Epstein-Barr virus infection in nasopharyngeal epithelial cells through K48-linked ubiquitination of HSP-90β.
Zhang M; Tan H; Gong Y; Faleti OD; Li D; Yang J; Huang J; Long J; Luo Q; Wu G; Zheng L; Lyu X
FASEB J; 2024 Jan; 38(1):e23345. PubMed ID: 38038978
[TBL] [Abstract][Full Text] [Related]
13. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract][Full Text] [Related]
14. USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression.
Wang W; Lei Y; Zhang G; Li X; Yuan J; Li T; Zhong W; Zhang Y; Tan X; Song G
Cell Death Dis; 2023 Jan; 14(1):63. PubMed ID: 36707504
[TBL] [Abstract][Full Text] [Related]
15. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor β-Induced Proliferative Arrest Mediated by TRIM26-Dependent TAF7 Degradation and Its Antagonism by MYC.
Nakagawa T; Hosogane M; Nakagawa M; Morohoshi A; Funayama R; Nakayama K
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203640
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53.
Lu H; Tan Z; Ko H; Naji P; Zhu R; Wang J; Huang S; Zhang YW; Zeng S
Res Sq; 2024 Jan; ():. PubMed ID: 38260302
[TBL] [Abstract][Full Text] [Related]
18. GNIP1 functions both as a scaffold protein and an E3 ubiquitin ligase to regulate autophagy in lung cancer.
Zhou F; Liu Y; Ai W; Wang Y; Gan M; Jiang Q; Han T; Wang JB
Cell Commun Signal; 2022 Aug; 20(1):133. PubMed ID: 36042481
[TBL] [Abstract][Full Text] [Related]
19. TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.
Luo M; Hou J; Mai H; Chen J; Chen H; Zhou B; Hou J; Jiang DK
Aliment Pharmacol Ther; 2022 Sep; 56(5):878-889. PubMed ID: 35872575
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of microRNA-365 is related to the occurrence and development of non-small-cell lung cancer by inhibiting TRIM25 expression.
Han Q; Cheng P; Yang H; Liang H; Lin F
J Cell Physiol; 2019 Dec; 234(12):22321-22330. PubMed ID: 31099423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
